stars 1 stars 2 stars 3

Hemics B.V. is a medical device company active in the field of Rheumatoid Arthritis (RA). Hemics' ambition is to improve the quality of life of patients with RA by creating imaging devices that support the rheumatologist in monitoring and treatment of this disease. Hemics' systems are based on patented optical inflammation detection technology, a non-invasive, fast and operator independent method that supports rheumatologists in objective assessment of inflammatory status, a key parameter in the treatment of patients with RA. Hemics was founded as a spin-off of Royal Philips Electronics where the inflammation detection technology was invented.

Hemics Questions

The Hemics annual revenue was $782000 in 2026.

Hemics is based in Eindhoven, North Brabant.

The NAICS codes for Hemics are [33, 339].

The SIC codes for Hemics are [38, 384].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users